$3.87
-0.18-4.44%
At Close: -
$3.71
-0.16-4.13%
After Hours: Jul 9, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Aprea Therapeutics
APRENASDAQ
Aprea Therapeutics (NASDAQ:APRE) Stock, Earnings Estimates, EPS, And Revenue
Aprea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.630
Quarterly Revenue Estimate
$50K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Aprea Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics | -$0.87 | -$0.63 | — | — | $249.69K | $50.00K | — | — | 08/08/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$1.34 | -$0.78 | -$0.67 | 14.10% | $0.00 | — | $380.57K | — | 05/14/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$0.92 | -$0.77 | -$0.92 | -19.48% | $0.00 | $110.00K | $14.07K | -87.20% | 03/26/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$2.40 | -$1.16 | -$0.86 | 25.86% | $0.00 | $80.00K | $319.47K | 299.34% | 11/09/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$19.80 | -$1.42 | -$0.87 | 38.73% | $0.00 | — | $249.69K | — | 08/10/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$7.20 | — | -$1.34 | — | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$7.20 | -$2.60 | -$0.92 | 64.62% | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$9.00 | -$5.40 | -$2.40 | 55.56% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$9.60 | -$7.40 | -$19.80 | -167.57% | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$9.20 | -$7.60 | -$7.20 | 5.26% | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$14.60 | -$8.80 | -$7.20 | 18.18% | $0.00 | — | $0.00 | — | 03/15/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$11.60 | -$8.80 | -$9.00 | -2.27% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$15.60 | -$9.60 | -$9.60 | 0.00% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$9.00 | -$9.80 | -$9.20 | 6.12% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$12.80 | — | -$14.60 | — | $0.00 | — | $0.00 | — | 03/16/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$105.80 | — | -$11.60 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| APRE | Aprea Therapeutics | -$89.00 | — | -$15.60 | — | — | — | $0.00 | — | 08/11/2020 | Get Alert |
| APRE | Aprea Therapeutics | -$59.40 | — | -$9.00 | — | — | — | $0.00 | — | 05/15/2020 | Get Alert |
| APRE | Aprea Therapeutics | -$81.00 | — | -$12.80 | — | — | — | $0.00 | — | 03/26/2020 | Get Alert |
| APRE | Aprea Therapeutics | — | — | -$105.80 | — | — | — | $0.00 | — | 11/14/2019 | Get Alert |
Aprea Therapeutics (APRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-0.67 | $-0.78 | 14.1 % |
| Dec 2023 | 2024-03-26 | $-0.92 | $-0.77 | -19.5 % |
| Sep 2023 | 2023-11-09 | $-0.86 | $-1.16 | 25.9 % |
| Jun 2023 | 2023-08-10 | $-0.87 | $-1.42 | 38.7 % |
Aprea Therapeutics (APRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-26 | $14.08K | $110.00K | -87.2 % |
| Sep 2023 | 2023-11-09 | $319.47K | $80.00K | 299.3 % |
FAQ
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics (APRE) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Aprea Therapeutics (NASDAQ:APRE)?
The Actual EPS was $-0.67, which beat the estimate of $-0.78.
What were Aprea Therapeutics’s (NASDAQ:APRE) revenues?
The Actual Revenue was $380.6K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.